Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-06-15

FDA Approved: SOLIFENACIN SUCCINATE — Original Application (Camber Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved Camber Pharmaceuticals' generic solifenacin succinate under an original ANDA submission, marking the approval of a generic version of the drug.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Solifenacin succinate (generic) (solifenacin succinate)

Snippet

ORIG AP for SOLIFENACIN SUCCINATE (SOLIFENACIN SUCCINATE)